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The UK Cellular Microbiology Network held its inaugural conference in February
2019. This stimulating day of scientific exchange will be the first of many, its orga-
nisers hope.1 | ARTICLE
In an era of vast conferences with thousands of participants, where
poster sessions may be held in halls the size of aircraft carriers, scien-
tists often find solace in smaller meetings. These allow better opportu-
nities for personal connections, but also permit focusing on topics that
seldom get much airplay in modern, multi‐stream mega‐symposia.
They can also serve to create and consolidate valuable regional or
national networks.
The cellular microbiology of bacterial pathogens is one such niche
topic within the greater umbrella of microbiology, with its exotic array
of viral, fungal, and bacterial microbes jockeying for position, alongside
the competing interests of the immunological response. In an era of
increasing antibiotic resistance, furthering our understanding of how
prokaryotes interact with their host cells, and developing novel ways
to intervene, has never been more important. Despite this imperative,
conferences focusing on this topic are rare, and its researchers are- - - - - - - - - - - - - - - - - - - - - - - - - -
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that they can sometimes feel like isolated members of a diaspora
and often struggle to meet valuable collaborators.
For this reason, we decided to organise an annual forum in the
United Kingdom—dubbed “The UK Cellular Microbiology Network”—
devoted to the cell biology of host‐bacterial interactions. Despite the
national emphasis, we were keen to welcome any of our geographical
neighbours who wished to attend. We wanted to focus specifically on
how bacterial pathogens subvert host cellular processes and how the
host cell responds. In creating an engaging, affordable, and informal
meeting showcasing the work of early‐career researchers, we hoped
to encourage the forging of useful collaborations and cross‐
fertilisation of diverse expertise and experiences about host cell biol-
ogy across the wide variety of bacterial pathogens under study.
Our inaugural one‐day meeting was held at London's Francis Crick
Institute on 11 February 2019 (Figure 1). About 140 researchers from
across the United Kingdom and a few other European countries- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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tatives of our generous sponsors, including the Microbiological Soci-
ety, the Biochemical Society, the British Society for Cell Biology, the
Journal of Cell Science, Perkin Elmer, Zeiss—and this journal, Cellular
Microbiology. In addition to the programme of talks, we also had a
vibrant poster session and ended the evening with drinks, nibbles,
and serious networking in the Crick's lovely gallery space.
The meeting kicked off with the first of our two keynote speakers,
Carmen Buchrieser from the Institut Pasteur in Paris. Challenging her
audience with the idea that Legionella is “the best cell biologist,” she
went on to describe some of her team's groundbreaking work
exploiting this bacterium to understand host cell function. In the first
half of her talk, she demonstrated how the bacterium, once phagocy-
tosed into lysosomes, secretes around 300 proteins to make a replica-
tive vacuole. In the process, it hijacks various host cytoskeletal
regulators to fragment mitochondria. This act of sabotage seems to
set up a “Warburg‐like” environment of high oxygen consumption
and high glycolysis that helps the microbes to replicate. Her team
identified a T4SS‐secreted effector of Legionella that is implicated in
inducing this mitochondrial fragmentation. Most interestingly, this
effector encodes protein domains normally only found in eukaryotes.
She then showed that such eukaryotic domains are a specific feature
of the Legionella genomes as she described an exciting comparative
functional analysis of 80 Legionella genomes spanning 58 species,
many of which have acquired the ability to infect eukaryotic cells inde-
pendently. Indeed, in the process, these species have co‐opted a large
number of host genes in order to subvert their hosts, courtesy of the
highly conserved type IV secretion system (T4SS).
Secretion—a popular virulence strategy amongst prokaryotes—fea-
tured in two additional talks. Focusing on the typhoid toxin produced
by the human pathogen Salmonella Typhi, Angela Ibler (from Dan
Humphreys' lab at the University of Sheffield) demonstrated beauti-
fully how secreted bacterial factors can have an impact on host cell
states. Using stunning super‐resolution microscopy images, she
showed that the toxin can induce a novel nuclear DNA damage
response, called the Response Induced by the bacterial Genotoxin
(RING), which was caused by replicative stress resulting from reduced
cellular levels of a single‐stranded DNA‐binding protein. Interestingly,
this new RING pathway also triggered a transmissible senescence‐like
state in cells, which in turn made cells more susceptible to S. Typhi
infection. This research suggests a new virulence mechanism that
may be relevant to chronic Salmonella infections. And Angela's talk
was so accomplished that she won the prize for best oral presenta-
tion—a pair of snazzy binoculars courtesy of Zeiss for whenever she
fancies taking a break from the microscope (The other binoculars prize
for best poster was scooped up by her labmate Mohamed El Ghazaly,
who presented his PhD work on identifying the proteins involved in
causing the senescence induced by S. Typhi).
Carrying on with the theme that bacterial pathogens employ a
number of secretion systems critical for intracellular bacterial survival,
Kate Watkins (from Meera Unnikrishnan's group at the University of
Warwick) presented her studies on the intriguing type VII bacterial
secretion system (T7SS) of the Gram positive pathogen,Staphylococcus aureus. Watkins demonstrated with striking timelapse
videomicroscopy images that S. aureus mutants lacking different com-
ponents of theT7SS were deficient in their ability to escape from mac-
rophages. She showed that T7SS modulated the type of cell death
triggered in macrophages, indicating a key role of this system in
S. aureus‐macrophage interactions.
Of course, macrophages are a popular host cell for a wide variety
of pathogens seeking to gain easy cellular entry and the upper hand
against the immune response. Their subversion formed another thread
at the meeting, and two talks about the obligate intracellular bacteria
Mycobacterium tuberculosis highlighted this theme. Susanne Herbst
(Max Gutierrez's lab at the Francis Crick Institute) showed that a
kinase commonly associated with Parkinson's disease, LRRK2, has an
immune function in macrophages. She showed that cultured primary
mouse and human macrophages lacking LRRK2 were able to better
control M. tuberculosis infection. On the basis of the data she pre-
sented, it is tempting to hypothesise that infectious diseases and mac-
rophage responses could play an important role in the pathogenesis of
Parkinson's disease. This finding adds to the growing evidence that the
immune response contributes to neurodegeneration, which may open
the door to innovative new therapies.
It is known that immune cell metabolism is key for the establish-
ment of an appropriate immune response. Eik Hoffmann (in Priscille
Brodin's lab from Pasteur Lille, France) showed that mice lacking the
enzyme IRG‐1, which regulates the production of the metabolite
Itaconate, are not able to control M. tuberculosis infection. Interest-
ingly, he showed that IRG‐1 is recruited to M. tuberculosis‐containing
phagosomes and that this enzyme is required for the control of bacte-
rial replication in macrophages. Immunometabolism is a field of grow-
ing interest, and knowing more about the role of such metabolites in
infection may lead to novel alternatives to antibiotics.
Carrying on with the hijacked macrophage theme, the group of
Marco Oggioni (University of Leicester) previously published that a sin-
gle founder bacterium of Streptococcus pneumoniae, sequestered within
splenic macrophages, can lead to sepsis after initial clearance in mice.
Joe Wanford from this group wanted to see whether this was the case
in humans. He reported an innovative organ‐slice perfusion model
derived from experimentally infected ex vivo human spleens from
patients undergoing elective splenectomy, which showed that intracel-
lular bacteria accumulate with time post‐clearance, after a single mono-
clonal founder replicates to form a cluster. These data have obvious
implications for how invasive pneumococcal disease should be treated.
Host cells are not always as vulnerable as they look, and cellular
mechanisms that recognise and eliminate invasive bacterial pathogens
are the subject of intense investigation. NRAMP1 (Natural Resistance‐
Associated Macrophage Protein 1, also called Slc11a1) is a divalent‐
metal efflux pump at the phagosomal membrane in macrophages,
and mutations in NRAMP1 cause susceptibility to several intracellular
pathogens. Using cutting edge single‐cell techniques, Olivier Cunrath
(Dirk Bumann's lab at the Biozentrum, University of Basel, Switzer-
land) is looking to identify the precise mechanism of NRAMP1‐
mediated resistance against Salmonella in vivo. Unexpectedly, he dis-
covered that NRAMP1‐mediated resistance against infection is
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infection control.
Previous work has shown that interferon exposure promotes cell‐
autonomous immunity for pathogen control, but the underlying mech-
anisms are poorly understood. Michal Wandel (Felix Randow's lab at
the, MRC Laboratory for Molecular Biology) discovered that members
of the interferon‐induced GTPase family of guanylate‐binding proteins
(GBPs) control Gram‐negative bacteria that can invade the cytosol
(e.g., Salmonella and Shigella). GBPs form a noncanonical
inflammasome on the pathogen surface to initiate pyroptotic cell
death of infected cells by recruiting and activating the cytosolic lipo-
polysaccharide receptor, Caspase‐4. Strikingly, Shigella can counteract
GBP‐mediated cell‐autonomous immunity to inhibit cell death and
form actin tails important for bacterial dissemination. As the next step,
it will be of great interest to investigate the precise function for GBPs
in host defence against cytosolic pathogens.
Ubiquitination of host and pathogen components defines much of
the downstream signalling that regulates the recognition and control
of intracellular pathogens. By using proteomics combinedwith the latex
bead model of phagosomes, Tiaan Heunis (Matthias Trost's lab at the
Newcastle University) showed us a holistic view of how proteins on
phagosomes of activated macrophages are ubiquitinated. He demon-
strated how immune activation qualitatively changes the phagosomal
ubiquitin‐linkage landscape, identifying a plethora of novel targets that
can potentially be modulated to target phagosomal pathogens. In fact,
some of these ubiquitin‐modulating targets that regulate phagosome
biology might be one day exploited as host‐directed therapies.
But the bacteria always seem to be one step ahead. Virtu Solano
Collado (from Stefania Spano's lab at the University of Aberdeen)
shared the latest update on her work investigating how Salmonella is
able to subvert host trafficking pathways. Virtu described how Salmo-
nella typhimurium effector proteins specifically target the small GTPase
Rab32 to promote intracellular survival. She also presented new
unpublished evidence of the importance of the Rab32/BLOC3 path-
way in controlling Salmonella Typhi infection.
The field of cellular microbiology is exploding in part due to excit-
ing advances in high resolution and high‐content microscopy. To
quantify image‐based host‐pathogen interactions in an unbiased man-
ner, Daniel Fisch (from Eva‐Maria Frickel's lab at the Francis Crick
Institute) employed an artificial intelligence workflow to develop an
image analysis platform called HRMAn (Host Response to Microbe
Analysis, at https://hrman.org/). Using a variety of intracellular patho-
gens including the cellular microbiology paradigm S. Typhimurium, he
showcased HRMAn's capacity to recognise and quantify various attri-
butes of host‐pathogen interactions. In this way, HRMAn can inspire a
broad range of cellular microbiologists to perform high‐content image
analysis.
The final speaker of the day (kindly sponsored by Cellular Micro-
biology) was Thierry Soldati from the University of Geneva. Soldati—
this journal's Editor‐in‐Chief—has pioneered the use of the amoeba
Dictyostelium discoideum as a surrogate host for mycobacterial infec-
tions. In his keynote speech, he summarised some of his team's dis-
coveries about how Mycobacterium marinum subvert and escape thephagosome, as well as spread between cells. He also described their
most recent work showing, intriguingly, how Dictyostelium cells
are able to exclude their infected brethren when they undergo mul-
ticellular development, effectively clearing the infection from the
population.
In conclusion, the first meeting of the new Network was highly
successful, exciting, and left everyone with much food for thought,
along with new connections. And we liked it so much that we are
doing it all over again in February 2020—this time in Sheffield. Please
do join us!
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